| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |